Learn, Analyse & Invest
only with
only with
+91
Download Orca
Ipca Laboratories Ltd.
Ipca Laboratories
Ipca Laboratories Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
Healthcare
Mid-cap - With a market cap of ₹485.13 Cr.
| EX-Date | Purpose |
|---|---|
| 28 05 2021 | Audited Results |
| 05 08 2021 | Quarterly Results |
| 13 11 2021 | Interim Dividend & Stock Split & Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 24 05 2022 | Audited Results & Amalgamation |
| 10 08 2022 | Quarterly Results |
| 11 11 2022 | Quarterly Results & Interim Dividend |
| 14 02 2023 | Quarterly Results |
| 29 05 2023 | Audited Results |
| 10 08 2023 | Quarterly Results |
| 10 11 2023 | Quarterly Results & Interim Dividend |
| 14 02 2024 | Quarterly Results |
| 30 09 2024 | Inter alia, to consider and approve:- (1) Integration and consolidation of the generics formulations business in the US market of M/s. Bayshore Pharmaceuticals LLC (wholly owned step-down subsidiary) into Unichem Pharmaceuticals (USA) Inc. (wholly owned subsidiary of Company?s subsidiary) |
| 14 11 2024 | Quarterly Results & Interim Dividend |
| 13 02 2025 | Quarterly Results |
| 29 05 2025 | Audited Results & Final Dividend |
| 13 11 2025 | Quarterly Results |
| 13 02 2026 | Quarterly Results |
| 29 05 2026 | Audited Results & Dividend |
| 13 08 2026 | Quarterly Results |
News
17-AUG-2026
Ipca Laboratories informs about analyst meet outcome
04:29 PM
14-AUG-2026
Ipca Laboratories - Quaterly Results
12:00 AM
28-JUL-2026
Ipca Laboratories informs about board meeting
10:06 AM
14-JUL-2026
Ipca Laboratories submits BRSR
01:13 PM
14-JUL-2026
Ipca Laboratories informs about annual report
11:22 AM
22-JUN-2026
Ipca Laboratories informs about trading window closure
11:25 AM
15-JUN-2026
Ipca Laboratories inks global licensing agreement with Bhami’s Research Laboratory
The company has been granted access to BRL’s proprietary high-concentration subcutaneous biologics delivery platform
02:10 PM
09-JUN-2026
Ipca Laboratories informs about newspaper publication
04:39 PM
01-JUN-2026
Ipca Laboratories informs about revised link for Q4FY26 conference call
12:03 PM
30-MAY-2026
Ipca Laboratories - Quaterly Results
12:00 AM
29-MAY-2026
Ipca Laboratories reports Profit after tax of Rs 2622.90 Mln, in the March 2026 quarter
01:55 PM
16-MAR-2026
Ipca Laboratories informs about trading window closure
03:10 PM
16-MAR-2026
Ipca Laboratories informs about closure of trading window
01:14 PM
14-FEB-2026
Ipca Laboratories - Quaterly Results
12:00 AM
13-FEB-2026
Ipca Laboratories reports Profit after tax of Rs 3034.50 Mln, in the December 2025 quarter
01:41 PM
09-FEB-2026
Ipca Laboratories receives USFDA’s EIR for Tarapur API facility
The EIR classifies the manufacturing facility as ‘Voluntary Action Indicated’
12:48 PM
07-FEB-2026
Ipca Laboratories informs about disclosure
01:18 PM
22-JAN-2026
Ipca Laboratories informs about board meeting
03:53 PM
13-JAN-2026
Ipca Laboratories informs about updates
11:45 AM
22-DEC-2025
Ipca Laboratories informs about closure of trading window
11:09 AM
05-DEC-2025
USFDA conducts inspection at Ipca Laboratories’ APIs manufacturing facility at Tarapur
At the conclusion of the inspection, USFDA has issued a Form 483 with 3 observations
04:42 PM
14-NOV-2025
Ipca Laboratories - Quaterly Results
12:00 AM
13-NOV-2025
Ipca Laboratories reports Profit after tax of Rs 3047.40 Mln, in the September 2025 quarter
01:45 PM
12-NOV-2025
Ipca Laboratories informs about conference call
02:13 PM
17-OCT-2025
Ipca Laboratories submits board meeting intimation
04:44 PM
16-OCT-2025
Ipca Laboratories incorporates subsidiary in Germany
The new entity has been incorporated to hold product registrations, participate in the institutional and other business and undertake distribution of generic formulations in Germany
03:00 PM
16-OCT-2025
Ipca Laboratories informs about incorporation of WOS
11:09 AM
11-AUG-2025
Ipca Laboratories - Quaterly Results
01:50 PM
11-AUG-2025
Ipca Laboratories - Quaterly Results
01:50 PM
11-AUG-2025
Ipca Laboratories - Quaterly Results
01:50 PM
11-AUG-2025
Ipca Laboratories reports Profit after tax of Rs 2620.40 Mln, in the June 2025 quarter
01:50 PM
11-JUL-2025
Ipca Laboratories informs about annual report
09:39 AM
10-JUL-2025
Ipca Laboratories informs about compliance certificate
04:57 PM
10-JUL-2025
Ipca Laboratories informs about compliance certificate
04:47 PM
24-JUN-2025
Ipca Laboratories informs about closure of trading window
10:02 AM
29-MAY-2025
Ipca Laboratories - Quaterly Results
01:54 PM
29-MAY-2025
Ipca Laboratories - Quaterly Results
01:54 PM
29-MAY-2025
Ipca Laboratories - Quaterly Results
01:54 PM
29-MAY-2025
Ipca Laboratories reports Profit after tax of Rs -650.50 Mln, in the March 2025 quarter
01:54 PM
02-MAY-2025
Ipca Laboratories informs about general updates
11:47 AM
07-APR-2025
Ipca Laboratories informs about compliance certificate
05:22 PM
03-MAR-2025
Ipca Laboratories informs about change in management
05:39 PM
13-FEB-2025
Ipca Laboratories - Quaterly Results
01:07 PM
13-FEB-2025
Ipca Laboratories reports Profit after tax of Rs 2675.60 Mln, in the December 2024 quarter
01:07 PM
13-FEB-2025
Ipca Laboratories - Quaterly Results
01:07 PM
13-FEB-2025
Ipca Laboratories - Quaterly Results
01:07 PM
27-JAN-2025
Ipca Laboratories informs about board meeting
11:11 AM
08-JAN-2025
Ipca Laboratories informs about compliances-certificate
05:24 PM
03-JAN-2025
IPCA Laboratories informs about change of name of RTA
04:54 PM
26-DEC-2024
Ipca Laboratories informs about trading window closure
02:51 PM
05-DEC-2024
Ipca Laboratories secures approval for voluntary closure of Mexico-based subsidiary
Voluntary closure of this wholly owned subsidiary will not have any impact on Company’s business or financials
12:21 PM
15-NOV-2024
Ipca Laboratories informs about newspaper publication
05:14 PM
14-NOV-2024
Ipca Laboratories - Quaterly Results
01:19 PM
14-NOV-2024
Ipca Laboratories reports Profit after tax of Rs 2441.20 Mln, in the September 2024 quarter
01:19 PM
14-NOV-2024
Ipca Laboratories - Quaterly Results
01:19 PM
14-NOV-2024
Ipca Laboratories - Quaterly Results
01:19 PM
04-OCT-2024
Ipca Laboratories informs about loss of share certificate
12:41 PM
23-SEP-2024
Ipca Laboratories informs about notice of board meeting and trading window closure
12:42 PM
20-SEP-2024
Ipca Laboratories informs about disclosure
11:09 AM
27-MAR-2024
Ipca Laboratories gains on entering into Technology Transfer Agreement with Omexa Formulary
Ipca will grant to Omexa a non-exclusive right to research, develop, manufacture and market a anti-cancer biosimilar for global market
03:29 PM
27-MAR-2024
Ipca Laboratories enters into Technology Transfer Agreement with Omexa Formulary
Ipca will grant to Omexa a non-exclusive right to research, develop, manufacture and market a anti-cancer biosimilar for global market
03:14 PM
21-MAR-2024
Ipca Laboratories informs about trading window closure
03:17 PM
27-FEB-2024
Ipca Laboratories informs about press release
04:34 PM
27-FEB-2024
IPCA Laboratories informs about postal ballot notice
01:03 PM
23-FEB-2024
Ipca Laboratories informs about notice of postal ballot
02:50 PM
16-FEB-2024
Ipca Laboratories informs about audio recording of conference call
10:42 AM
14-FEB-2024
Ipca Laboratories - Quaterly Results
01:42 PM
14-FEB-2024
Ipca Laboratories reports Profit after tax of Rs 1369.40 Mln, in the December 2023 quarter
01:42 PM
14-FEB-2024
Ipca Laboratories - Quaterly Results
01:42 PM
14-FEB-2024
Ipca Laboratories - Quaterly Results
01:42 PM
25-JAN-2024
lpca Laboratories informs about loss of share certificate
02:20 PM
22-JAN-2024
IPCA Laboratories submits board meeting intimation
02:52 PM
10-JAN-2024
Ipca Laboratories informs about compliance certificate
02:33 PM
22-NOV-2023
Ipca Laboratories informs about loss of share certificate
03:23 PM
13-NOV-2023
Ipca Laboratories informs about press release
05:01 PM
13-NOV-2023
Ipca Laboratories gains despite reporting 6% fall in Q2 consolidated net profit
Total consolidated income of the company increased by 26.59% at Rs 2,072.51 crore for Q2FY24
03:16 PM
13-NOV-2023
Ipca Laboratories reports 6% fall in Q2 consolidated net profit
Total consolidated income of the company increased by 26.59% at Rs 2,072.51 crore for Q2FY24
03:12 PM
13-NOV-2023
Ipca Laboratories informs about loss of share certificate
02:51 PM
10-NOV-2023
Ipca Laboratories - Quaterly Results
01:39 PM
10-NOV-2023
Ipca Laboratories - Quaterly Results
01:39 PM
10-NOV-2023
Ipca Laboratories - Quaterly Results
01:39 PM
10-NOV-2023
Ipca Laboratories reports Profit after tax of Rs 1621.30 Mln, in the September 2023 quarter
01:39 PM
31-OCT-2023
Ipca Laboratories gets VAI classification for Indore facility
USFDA inspected the company’s said manufacturing facility from June 15, 2023 to June 23, 2023
11:52 AM
31-OCT-2023
Ipca Laboratories informs about disclosure
10:07 AM
25-OCT-2023
Ipca Laboratories informs about board meeting
05:02 PM
23-OCT-2023
Ipca Laboratories zooms despite getting VAI classification for Madhya Pradesh facility
USFDA inspected the company’s said manufacturing facility from June 05, 2023 to June 13, 2023
11:50 AM
23-OCT-2023
Ipca Laboratories gets VAI classification for Madhya Pradesh facility
USFDA inspected the company’s said manufacturing facility from June 05, 2023 to June 13, 2023
11:40 AM
24-AUG-2023
Ipca Laboratories gets VAI classification for Piparia manufacturing facility
Based on this inspection, this facility is considered to be in a minimally acceptable state of compliance with regards to current good manufacturing practice
10:21 AM
10-AUG-2023
Ipca Laboratories - Quaterly Results
01:08 PM
10-AUG-2023
Ipca Laboratories - Quaterly Results
01:08 PM
10-AUG-2023
Ipca Laboratories - Quaterly Results
01:08 PM
10-AUG-2023
Ipca Laboratories reports Profit after tax of Rs 1665.80 Mln, in the June 2023 quarter
01:08 PM
03-AUG-2023
Ipca Laboratories surges on acquiring 33.38% stake in Unichem Laboratories
This deal was executed through block deal mechanism of National Stock Exchange of India
10:38 AM
03-AUG-2023
Ipca Laboratories acquires 33.38% stake in Unichem Laboratories
This deal was executed through block deal mechanism of National Stock Exchange of India
10:30 AM
27-JUL-2023
IPCA Laboratories informs about disclosure
09:32 AM
10-JUL-2023
Ipca Laboratories informs about annual report
09:41 AM
24-JUN-2023
USFDA conducts inspection at Ipca Laboratories’ formulations manufacturing facility in Pithampur
At the conclusion of the inspection, USFDA has issued a Form 483 with 8 observations
10:51 AM
14-JUN-2023
Ipca Laboratories informs about inspection of Company’s manufacturing facility
09:43 AM
14-JUN-2023
USFDA conducts inspection at Ipca Laboratories’ APIs manufacturing facility at Ratlam
At the conclusion of the inspection, the USFDA issued a Form 483 with 11 observations
09:31 AM
02-JUN-2023
Ipca Laboratories informs about newspaper publication
10:29 AM
30-MAY-2023
Ipca Laboratories informs about cancellation of conference call
05:15 PM
29-MAY-2023
Ipca Laboratories - Quaterly Results
01:40 PM
29-MAY-2023
Ipca Laboratories reports Profit after tax of Rs 848.20 Mln, in the March 2023 quarter
01:40 PM
29-MAY-2023
Ipca Laboratories - Quaterly Results
01:40 PM
29-MAY-2023
Ipca Laboratories - Quaterly Results
01:40 PM
27-APR-2023
Ipca Laboratories informs about updates
09:59 AM
27-APR-2023
USFDA conducts inspection at Ipca Laboratories’ formulations manufacturing unit at Piparia
At the conclusion of the inspection, the USFDA issued a Form 483 with 3 observations
09:24 AM
24-APR-2023
Ipca Laboratories inks pact to acquire 33.4% stake in Unichem Laboratories
The business and product range of Ipca and that of Unichem complements each others business and product range
04:58 PM
31-MAR-2023
Ipca Laboratories informs about closure of trading window
10:02 AM
14-FEB-2023
Ipca Laboratories - Quaterly Results
01:07 PM
14-FEB-2023
Ipca Laboratories - Quaterly Results
01:07 PM
14-FEB-2023
Ipca Laboratories - Quaterly Results
01:07 PM
09-FEB-2023
Ipca Laboratories informs about conference call
05:06 PM
20-DEC-2022
Ipca Laboratories gains on acquiring further 6.53% stake in Trophic Wellness
Cash Consideration of Rs 10.58 crore was paid for the additional acquisition of 6.53% shareholding of TWPL
12:25 PM
20-DEC-2022
Ipca Laboratories acquires further 6.53% stake in Trophic Wellness
Cash Consideration of Rs 10.58 crore was paid for the additional acquisition of 6.53% shareholding of TWPL
09:21 AM
11-NOV-2022
Ipca Laboratories reports Profit after tax of Rs 1677.80 Mln, in the September 2022 quarter
01:24 PM
11-NOV-2022
Ipca Laboratories - Quaterly Results
01:24 PM
11-NOV-2022
Ipca Laboratories - Quaterly Results
01:24 PM
11-NOV-2022
Ipca Laboratories - Quaterly Results
01:24 PM
12-OCT-2022
lpca Laboratories informs about revised copy of the certificate
10:39 AM
10-AUG-2022
Ipca Laboratories reports Profit after tax of Rs 1438.20 Mln, in the June 2022 quarter
01:20 PM
10-AUG-2022
Ipca Laboratories - Quaterly Results
01:20 PM
10-AUG-2022
Ipca Laboratories - Quaterly Results
01:20 PM
03-AUG-2022
Ipca Laboratories informs about demise of independent director
09:54 AM
27-MAY-2022
Ipca Laboratories - Quaterly Results
02:01 PM
24-MAY-2022
Ipca Laboratories - Quaterly Results
01:11 PM
24-MAY-2022
Ipca Laboratories reports Profit after tax of Rs 1104.10 Mln, in the March 2022 quarter
01:11 PM
24-MAY-2022
Ipca Laboratories - Quaterly Results
01:11 PM